Francois Brisebois analyst OPPENHEIMER

Currently out of the existing stock ratings of Francois Brisebois, 100 are a BUY (93.46%), 7 are a HOLD (6.54%).

Francois Brisebois

Work Performance Price Targets & Ratings Chart

Analyst Francois Brisebois, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 21.44% that have a potential upside of 31.17% achieved within 138 days.

Francois Brisebois’s has documented 200 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TARS, Tarsus Pharmaceuticals  at 14-Nov-2024.

Wall Street Analyst Francois Brisebois

Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for DMTK (DERMTECH) at 1/22/2021. The price target of $53 was fulfilled within 14 days with a profit of $10.08 (23.49%) receiving and performance score of 16.78.

Average potential price target upside

AVDL Avadel Pharmaceuticals PLC DRRX Durect FLXN Flexion Therapeutics HRMY Harmony Biosciences Holdings ICAD icad inc KALA Kala Pharmaceuticals ACHV Achieve Life Sciences AQST Aquestive Therapeutics CMPS Compass Pathways Plc DMTK DermTech ICPT Intercept Pharmaceuticals OTIC Otonomy CYBN Cybin  DMAC DiaMedica Therapeutics PCSA Processa Pharmaceuticals TARS Tarsus Pharmaceuticals  SLP Simulations Plus MDWD Mediwound Ltd MNMD Mind Medicine  BNGO Bionano Genomics DYN Dyne Therapeutics  MDXH MDxHealth SA ADR SERA Sera Prognostics SVRA Savara

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$11.09 (101.65%)

$22

7 days ago
(13-Nov-2024)

20/30 (66.67%)

$9.84 (80.92%)

319

Buy

$25

$14.09 (129.15%)

$27

7 days ago
(13-Nov-2024)

4/11 (36.36%)

$12.84 (105.59%)

380

Buy

$30

$19.09 (174.98%)

$27

20 days ago
(31-Oct-2024)

6/14 (42.86%)

$14.53 (93.92%)

440

Buy

$18

$7.09 (64.99%)

$18

1 years 3 months 10 days ago
(10-Aug-2023)

4/4 (100%)

$4.57 (34.03%)

1060

Buy

$18

$4.69 (35.24%)

$16

1 years 4 months 22 days ago
(30-Jun-2023)

2/4 (50%)

$1.52 (9.22%)

169

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Francois Brisebois is most bullish on?

Potential upside of $36.17 has been obtained for SLP (SIMULATIONS PLUS)

Which stock is Francois Brisebois is most reserved on?

Potential downside of $1.89 has been obtained for DMAC (DIAMEDICA THERAPEUTICS)

What Year was the first public recommendation made by Francois Brisebois?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?